Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis

Figure 3 Evolution of stool consistency in irritable bowel syndrome-C subjects during the 8-wk supplementation with active product (Saccharomyces cerevisiae CNCM I-3856, white squares) or placebo product (black circles). Values are estimated means, with standard error represented by vertical bars. ^aP < 0.05, ^bP < 0.01, Significant differences, vs placebo are symbolized. IBS-C: Irritable bowel syndrome-C; a.u.: Arbitrary unit.